Woodline Partners’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-696,225
Closed -$8.08M 1162
2026
Q1
$8.08M Buy
+696,225
New +$8.68M 0.03% 563
2022
Q3
Sell
-179,001
Closed -$6.4M 831
2022
Q2
$6.4M Buy
+179,001
New +$7.24M 0.1% 224
2021
Q2
Sell
-53,528
Closed -$3.42M 631
2021
Q1
$3.42M Sell
53,528
-129,042
-71% -$7.48M 0.08% 231
2020
Q4
$9.56M Sell
182,570
-115,409
-39% -$5.69M 0.25% 119
2020
Q3
$13M Buy
297,979
+186,042
+166% +$8.23M 0.43% 70
2020
Q2
$4.93M Buy
+111,937
New +$4.73M 0.2% 114
2020
Q1
Sell
-398,922
Closed -$22.6M 174
2019
Q4
$22.6M Buy
+398,922
New +$22.2M 0.92% 43

Other funds holding XRAY

Woodline Partners's XRAY Position: Q2 2026 in Review

Woodline Partners sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 696,225 shares — an estimated $8.08M sold.

Woodline Partners first reported a position in XRAY in Q4 2019 and held it in 7 quarters. The position peaked at $22.6M in Q4 2019. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Woodline Partners reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 696,225 Dentsply Sirona shares in Q2 2026, an estimated $8.08M.
  • Woodline Partners first reported a position in Dentsply Sirona in Q4 2019 and held it in 7 quarters.
  • Woodline Partners's Dentsply Sirona position peaked at $22.6M in Q4 2019.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.